| 1 |
王 笑，李 鑫，杨学刚，等. 非小细胞肺癌微波消融术后血清Caspase-4变化及意义[J/CD]. 中华肺部疾病杂志(电子版), 2020, 13(2): 218-222.
|
| 2 |
Duma N, Santana-Davila R, Molina JR. Non-small cell lung cancer: Epidemiology, screening, diagnosis, and treatment[J]. Mayo Clin Proc, 2019, 94(8): 1623-1640.
|
| 3 |
Arbour KC, Riely GJ. Systemic therapy for locally advanced and metastatic non-small cell lung cancer: A review[J]. JAMA, 2019, 322(8): 764-774.
|
| 4 |
张秀义，许浩然，孙亚东. 非小细胞肺癌中p-mTOR，Beclin1及Atg1蛋白表达及其临床意义[J/CD]. 中华肺部疾病杂志(电子版), 2020, 13(5): 633-638.
|
| 5 |
高 岩，辛雯艳，王 蓓，等. 微小RNA708靶向调控FOXO3表达及对非小细胞肺癌细胞增殖，侵袭和迁移的影响[J]. 临床肿瘤学杂志，2019, 24(10): 886-890.
|
| 6 |
Clemenceau A, Diorio C, Durocher F. Role of secreted frizzled-related protein 1 in early mammary gland tumorigenesis and its regulation in breast microenvironment[J]. Cells, 2020, 9(1): 208-215.
|
| 7 |
Krishnamurthy N, Kurzrock R. Targeting the Wnt/beta-catenin pathway in cancer: Update on effectors and inhibitors[J]. Cancer Treat Rev, 2018, 62(3): 50-60.
|
| 8 |
Li Y, Chen F, Shen W, et al. WDR74 induces nuclear β-catenin accumulation and activates Wnt-responsive genes to promote lung cancer growth and metastasis[J]. Cancer Lett, 2020, 471(10): 103-115.
|
| 9 |
陆 舜，纪文翔，虞永峰. 2014版《NCCN非小细胞肺癌临床实践指南》更新解读[J]. 中国医师进修杂志，2015, 38(38): 318-320.
|
| 10 |
弗赖雷，卡格尔，欧 文，等. 肺肿瘤病理学图谱：组织病理学、细胞病理学、内镜和影像学[M]. 北京市：北京科学技术出版社，2013: 96-97.
|
| 11 |
Broderick SR. Adjuvant and neoadjuvant immunotherapy in non-small cell lung cancer[J]. Thorac Surg Clin, 2020, 30(2): 215-220.
|
| 12 |
Sankar K, Gadgeel SM, Qin A. Molecular therapeutic targets in non-small cell lung cancer [J]. Expert Rev Anticancer Ther, 2020, 20(8): 647-661.
|
| 13 |
刘天艺. Oct4 mRNA在非小细胞肺癌患者肿瘤组织的表达与病理特征的相关性分析[J/CD]. 中华肺部疾病杂志(电子版), 2019, 12(3): 342-344.
|
| 14 |
Lee SS, Cheah YK. The interplay between microRNAs and cellular components of tumour microenvironment (TME) on non-small-cell lung cancer (NSCLC) progression[J]. J Immunol Res, 2019, 588(6): 151-156.
|
| 15 |
Kohsaka S, Petronczki M, Solca F, et al. Tumor clonality and resistance mechanisms in EGFR mutation-positive non-small-cell lung cancer: implications for therapeutic sequencing[J]. Future Oncol, 2019, 15(6): 637-652.
|
| 16 |
Clamon G, Zeitler W, An J, et al. Transformational changes between non-small cell and small cell lung cancer-biological and clinical relevance- a review[J]. Am J Clin Oncol, 2020, 43(9): 670-675.
|
| 17 |
Yang F, Xu J, Li H, et al. FBXW2 suppresses migration and invasion of lung cancer cells via promoting β-catenin ubiquitylation and degradation[J]. Nat Commun, 2019, 10(1): 1382-1391.
|
| 18 |
Cheng LC, Chao YJ, Overman MJ, et al. Increased expression of secreted frizzled related protein 1 (SFRP1) predicts ampullary adenocarcinoma recurrence[J]. Sci Rep, 2020, 10(1): 1325-1330.
|
| 19 |
Wang Z, Li R, He Y, et al. Effects of secreted frizzled-related protein 1 on proliferation, migration, invasion, and apoptosis of colorectal cancer cells[J]. Cancer Cell Int, 2018, 18(6): 48-56.
|
| 20 |
Cho SH, Kuo IY, Lu PF, et al. Rab37 mediates exocytosis of secreted frizzled-related protein 1 to inhibit Wnt signaling and thus suppress lung cancer stemness[J]. Cell Death Dis, 2018, 9(9): 868-874.
|
| 21 |
Wang J, Zhao J, Zhu J, et al. Hypoxic non-small-cell lung cancer cell-secreted exosomal microRNA-582-3p drives cancer cell malignant phenotypes by targeting secreted frizzled-related protein 1[J]. Cancer Manag Res, 2020, 12(7): 10151-10161.
|
| 22 |
Huang JQ, Wei FK, Xu XL, et al. SOX9 drives the epithelial-mesenchymal transition in non-small-cell lung cancer through the Wnt/β-catenin pathway[J]. J Transl Med, 2019, 17(1): 143-150.
|
| 23 |
张冉冉，朱 琳，于佳晴，等. 低表达UHRF1通过Wnt/β-catenin信号通路抑制非小细胞肺癌细胞增殖能力的研究[J]. 国际免疫学杂志，2019, 42(4): 365-370.
|
| 24 |
Pan J, Fang S, Tian H, et al. lncRNA JPX/miR-33a-5p/Twist1 axis regulates tumorigenesis and metastasis of lung cancer by activating Wnt/β-catenin signaling[J]. Mol Cancer, 2020, 19(1): 9-15.
|
| 25 |
Katoh M. Multi-layered prevention and treatment of chronic inflammation，organ fibrosis and cancer associated with canonical WNT/β-catenin signaling activation (Review) [J]. Int J Mol Med, 2018, 42(2): 713-725.
|